TipRanks
Advertisement
Advertisement

ABUS Stock Latest News

Largest borrow rate increases among liquid names
The FlyLargest borrow rate increases among liquid names
13d ago
NRG
RGR
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
19d ago
BSP
CPB
Arbutus Biopharma’s US$230 Million Share Buyback Oversubscribed
PremiumCompany Announcements
Arbutus Biopharma’s US$230 Million Share Buyback Oversubscribed
21d ago
ABUS
Arbutus Biopharma Launches US$230 Million Dutch Auction Share Buyback
PremiumCompany Announcements
Arbutus Biopharma Launches US$230 Million Dutch Auction Share Buyback
2M ago
ABUS
Arbutus Biopharma commences $230M modified Dutch Auction tender offer
PremiumThe Fly
Arbutus Biopharma commences $230M modified Dutch Auction tender offer
2M ago
ABUS
Midday Fly By: BJ’s reports Q2 beat, Broadcom in talks to raise $60B of debt
PremiumThe FlyMidday Fly By: BJ’s reports Q2 beat, Broadcom in talks to raise $60B of debt
2M ago
C
BJ
Arbutus Biopharma Announces Major Share Repurchase Tender Offer
Premium
Company Announcements
Arbutus Biopharma Announces Major Share Repurchase Tender Offer
2M ago
8K
ABUS
Arbutus Biopharma to repurchase $230M of shares through Dutch Auction
Premium
The Fly
Arbutus Biopharma to repurchase $230M of shares through Dutch Auction
2M ago
ABUS
Arbutus Boosts Cash With Moderna Settlement, Advances Hepatitis B Program
PremiumCompany Announcements
Arbutus Boosts Cash With Moderna Settlement, Advances Hepatitis B Program
2M ago
ABUS
Arbutus Biopharma (ABUS) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Arbutus Biopharma (ABUS) Q2 Earnings Cheat Sheet
3M ago
ABUS
Arbutus Biopharma Reshapes Strategy After Moderna Settlement
PremiumCompany Announcements
Arbutus Biopharma Reshapes Strategy After Moderna Settlement
3M ago
8K
ABUS
Arbutus Biopharma expects to return $230M in capital to shareholders
PremiumThe Fly
Arbutus Biopharma expects to return $230M in capital to shareholders
3M ago
ABUS
Arbutus initiates patent infringement actions against Pfizer, BioNTech
PremiumThe FlyArbutus initiates patent infringement actions against Pfizer, BioNTech
3M ago
PFE
ABUS
Arbutus Biopharma receives $178M settlement agreement from Moderna
Premium
The Fly
Arbutus Biopharma receives $178M settlement agreement from Moderna
3M ago
ABUS
MRNA
Arbutus Biopharma Shareholders Approve New 2026 Incentive Plan
Premium
Company Announcements
Arbutus Biopharma Shareholders Approve New 2026 Incentive Plan
5M ago
8K
ABUS
Arbutus Biopharma Shareholders Approve New 2026 Incentive Plan
PremiumCompany Announcements
Arbutus Biopharma Shareholders Approve New 2026 Incentive Plan
5M ago
8K
ABUS
ABUS Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ABUS Earnings this Week: How Will it Perform?
6M ago
ABUS
Arbutus Biopharma Gains FDA Fast Track for Imdusiran
PremiumCompany Announcements
Arbutus Biopharma Gains FDA Fast Track for Imdusiran
6M ago
8K
ABUS
Arbutus Biopharma granted Fast Track designation for imdusiran
PremiumThe Fly
Arbutus Biopharma granted Fast Track designation for imdusiran
6M ago
ABUS
Roivant Sciences price target raised to $34 from $30 at Jefferies
PremiumThe FlyRoivant Sciences price target raised to $34 from $30 at Jefferies
7M ago
ABUS
MRNA
Arbutus Biopharma price target lowered to $5.50 from $7 at Jefferies
Premium
The Fly
Arbutus Biopharma price target lowered to $5.50 from $7 at Jefferies
7M ago
ABUS
MRNA
Arbutus Boosted by $2.25 Billion LNP Settlement and Hepatitis B Trial Progress
Premium
Company Announcements
Arbutus Boosted by $2.25 Billion LNP Settlement and Hepatitis B Trial Progress
7M ago
ABUS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >